Results 151 to 160 of about 22,234 (251)

A Large Study on Immunological Response to a Whole-Cell Killed Oral Cholera Vaccine Reveals That There Are Significant Geographical Differences in Response and That O Blood Group Individuals Do Not Elicit a Higher Response

, 2010
Thandavarayan Ramamurthy, Diane K. Wagener, Goutam Chowdhury, Partha P. Majumder   +3 more
openalex   +1 more source

Albendazole Treatment of Children with Ascariasis Enhances the Vibriocidal Antibody Response to the Live Attenuated Oral Cholera Vaccine CVD 103‐HgR [PDF]

, 2000
Philip J. Cooper, Martha Chico, Genevieve A. Losonsky, Carlos Sandoval, Ivan Espinel, Rajeshwari Sridhara, M. Rodríguez Aguilar, Angel Guevara, Ronald H. Guderian, Myron M. Levine, George E. Griffin, Thomas B. Nutman   +11 more
openalex   +1 more source

Dual-Use Vaccine for Diarrhoeal Diseases: Cross-Protective Immunogenicity of a Cold-Chain-Free, Live-Attenuated, Oral Cholera Vaccine against Enterotoxigenic Escherichia coli (ETEC) Challenge in BALB/c Mice. [PDF]

Vaccines (Basel), 2022
Hui Xian T, Parasuraman S, Ravichandran M, Prabhakaran G.   +3 more
europepmc   +1 more source

Gut bacteria-derived sphingolipids alter innate immune responses to oral cholera vaccine antigens. [PDF]

Nat Commun
Chac D, Heller FJ, Banna HA, Kaisar MH, Markiewicz SM, Pruitt EL, Chowdhury F, Bhuiyan TR, Akter A, Khan AI, Dumayas MG, Rice A, Karmakar PC, Dash P, LaRocque RC, Ryan ET, Xu L, Minot SS, Harris JB, Qadri F, Weil AA.   +20 more
europepmc   +1 more source

Effect of HIV status and retinol on immunogenicity to oral cholera vaccine in adult population living in an endemic area of Lukanga Swamps, Zambia. [PDF]

PLoS One, 2021
Luchen CC, Mwaba J, Ng'ombe H, Alabi PIO, Simuyandi M, Chilyabanyama ON, Hatyoka LM, Mubanga C, Bosomprah S, Chilengi R, Chisenga CC.   +10 more
europepmc   +1 more source

Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial [PDF]

, 2018
Lina Cordero De Los Santos, Jesús Feris-Iglesias, Naveena Aloysia D’Cor, Venkata Jayanth Midde, Badri Narayan Patnaik, Yaël Thollot, Anvar Rasuli, Eric Desauziers   +7 more
openalex   +1 more source

Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial. [PDF]

Lancet Infect Dis, 2021
Ali M, Qadri F, Kim DR, Islam MT, Im J, Ahmmed F, Khan AI, Zaman K, Marks F, Kim JH, Clemens JD.   +10 more
europepmc   +1 more source

Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults [PDF]

, 1995
Stanley J. Cryz, J U Que, Myron M. Levine, G Wiedermann, Herwig Kollaritsch   +4 more
openalex   +1 more source

Descriptive analysis of adverse events following immunization with oral cholera vaccine in Lebanon. [PDF]

Front Public Health
Zeitoun A, Ibrahim A, Reda El Sayed S, Hobeika E, Karam R.   +4 more
europepmc   +1 more source

Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine. [PDF]

Am J Trop Med Hyg, 2021
Akter A, Kelly M, Charles RC, Harris JB, Calderwood SB, Bhuiyan TR, Biswas R, Xu P, Kováč P, Qadri F, Ryan ET.   +10 more
europepmc   +1 more source